Does SECUKINUMAB Cause Increased bronchial secretion? 14 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Increased bronchial secretion have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.0% of all adverse event reports for SECUKINUMAB.
14
Reports of Increased bronchial secretion with SECUKINUMAB
0.0%
of all SECUKINUMAB reports
0
Deaths
11
Hospitalizations
How Dangerous Is Increased bronchial secretion From SECUKINUMAB?
Of the 14 reports, 11 (78.6%) required hospitalization.
Is Increased bronchial secretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Increased bronchial secretion?
ALBUTEROL (637)
OMALIZUMAB (144)
MEPOLIZUMAB (119)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (93)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (87)
FLUTICASONE\SALMETEROL (86)
FLUTICASONE (82)
PREDNISONE (74)
TIOTROPIUM (65)
BUDESONIDE\FORMOTEROL (63)
Which SECUKINUMAB Alternatives Have Lower Increased bronchial secretion Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG